Clinical Trials Browser

Phase 1 × Oligodendroglioma × Bevacizumab × Clear all

NCT01392209 2019-11-22

Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma

Phase 1 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma

NCT01339039 2017-11-17

Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma

Phase 1 Terminated

Astrocytoma, Oligodendroglioma